The vasodilator-stimulated phosphoprotein (VASP 1 ) is a major substrate for cyclic nucleotide-dependent kinases in platelets and other cardiovascular cells. It promotes actin nucleation and binds to actin filaments in vitro and associates with stress fibers in cells. The VASP-actin interaction is salt-sensitive, arguing for electrostatic interactions. Hence, phosphorylation may significantly alter the actin-binding properties of VASP. This hypothesis was investigated by analyzing complex formation of recombinant murine VASP with actin after phosphorylation with cAMP-dependent kinase (PKA) in different assays. PKA phosphorylation had a negative effect on both, actin nucleation as well as VASP interaction with actin filaments, with the actin nucleating capacity being more affected than actin filament binding and bundling. Replacing VASP residues known to be phosphorylated in vivo by acidic residues to mimic phosphorylation, had similar although less dramatic effects on VASP-actin interactions. In contrast, phosphorylation had no significant effect on VASP oligomerization or its interaction with its known ligands profilin, vinculin and zyxin. When overexpressing VASP mutants in eukaryotic cells, they all showed targeting to focal contacts and stress fibers. Our results imply that VASP phosphorylation may act as an immediate negative regulator of actin dynamics.
Summary
The vasodilator-stimulated phosphoprotein (VASP 1 ) is a major substrate for cyclic nucleotide-dependent kinases in platelets and other cardiovascular cells. It promotes actin nucleation and binds to actin filaments in vitro and associates with stress fibers in cells. The VASP-actin interaction is salt-sensitive, arguing for electrostatic interactions. Hence, phosphorylation may significantly alter the actin-binding properties of VASP. This hypothesis was investigated by analyzing complex formation of recombinant murine VASP with actin after phosphorylation with cAMP-dependent kinase (PKA) in different assays. PKA phosphorylation had a negative effect on both, actin nucleation as well as VASP interaction with actin filaments, with the actin nucleating capacity being more affected than actin filament binding and bundling. Replacing VASP residues known to be phosphorylated in vivo by acidic residues to mimic phosphorylation, had similar although less dramatic effects on VASP-actin interactions. In contrast, phosphorylation had no significant effect on VASP oligomerization or its interaction with its known ligands profilin, vinculin and zyxin. When overexpressing VASP mutants in eukaryotic cells, they all showed targeting to focal contacts and stress fibers. Our results imply that VASP phosphorylation may act as an immediate negative regulator of actin dynamics.
Introduction
Cell morphology and motility critically depend on the remodeling of the cytoskeletal architecture in response to external stimuli. Directional locomotion requires locally confined membrane protrusion driven by actin polymerization, resulting in the formation of a leading edge. Adhesion to the extracellular matrix is mediated by distinct multi-protein complexes.
The formation of these focal adhesions is initiated by the activation of integrin heterodimers, which then recruit a variety of cytoskeletal and signaling molecules (1) . Most of the cytoskeletal components involved, e.g. talin, α-actinin and vinculin, are multi-ligand proteins.
They may function as structural scaffolds for other cytoskeletal and signaling proteins or interact directly with the actin cytoskeleton. Given the complexity of focal adhesions, actin dynamics at these sites is not completely understood and the final integration of integrinmediated signaling with de novo actin polymerization remains to be elucidated.
Several lines of evidence have implicated the vasodilator-stimulated phosphoprotein (VASP)
to be involved in the regulation of filament assembly and organization. VASP was originally purified from human platelets (2) . It belongs to a protein family including the Drosophila protein Enabled (Ena), its mammalian homologue Mena and the Ena-VASP-like protein (Evl) (3) . They all share a common domain structure comprising a central proline-rich core flanked by two highly conserved Ena-VASP homology domains (3)(EVH1 and EVH2, Fig. 1 ).
Ena/VASP proteins target to the leading edge and focal adhesions in fibroblasts (3, 4) , which is mediated by the EVH1 domain recognizing the consensus motif D/E FPPPXD (5, 6 ). This motif is present in several VASP ligands, including zyxin and vinculin. The central region of Ena/VASP proteins harbors proline-rich stretches that are recognized by the G-actin-binding protein profilin (3, 7) . VASP oligomerization and F-actin binding are confined to the Cterminal EVH2 domain (3, 8, 9) . VASP may thus control the actin cytoskeleton by three different mechanisms: (I) it may recruit G-actin via its binding to profilin, (II) it may stabilize by guest on September 14, 2017 http://www.jbc.org/ Downloaded from and possibly organize newly formed filaments by direct binding to F-actin and (III) oligomerization may potentiate both effects.
VASP is highly enriched in platelets (10) and it is phosphorylated in response to vasodilators and platelet inhibitors, substances that raise intracellular cAMP and cGMP levels. VASP has been shown to be an immediate target for PKA and PKG in vitro and in vivo (11) and its phosphorylation correlates with the inhibition of platelet aggregation (12) . These data are further supported by genetic analyses from VASP knockout mice that display enhanced agonist-induced platelet aggregation (13, 14) . How platelet inhibition is mediated by VASP is currently unknown, but phosphorylation seems to be a key factor. VASP is phosphorylated in vitro and in intact human platelets at three residues by both PKA and PKG (11) , corresponding to residues S153, S235 and T274 in murine VASP (8) . All three phosphorylation sites are positioned close to ligand-binding modules ( Fig. 1 ): S153 is located N-terminally of the (GP 5 ) 3 motif in the proline-rich region which has been shown to bind to profilin (15) . In the EVH2 domain, S235 and T274 neighbor basic stretches that seem to mediate VASP-actin interactions (8, 9) . Hence the ligand-binding properties of VASP may significantly be altered by phosphorylation.
So far, VASP-ligand interactions and VASP phosphorylation have mainly been investigated separately yielding little information about how these two are related. The aim of the present study was to directly analyze the influence of phosphorylation on VASP-ligand complex formation. Recombinant VASP was phosphorylated by PKA in vitro and tested in different assays for actin-binding, oligomerization and the interaction with its known ligands profilin, vinculin and zyxin. These experiments reveal that VASP phosphorylation by PKA diminishes binding to F-actin and even suppresses actin nucleation, whereas oligomerization and ligandbinding remain unaffected. Our data lead to a model, in which phosphorylation serves as a direct regulatory switch for VASP-mediated actin polymerization at adhesion sites. 
Experimental Procedures

Cloning of VASP constructs
Cloning of murine VASP and its EVH1 and EVH2 domains has already been reported (8) .
The constructs comprising either EVH-domain or the proline-rich domain (EVH1-P; P-EVH2) were generated accordingly by PCR using full length VASP as a template.
Amplification primers introduced EcoRI and XhoI restriction sites for further cloning into the following vectors: pQE30 (Qiagen, Hilden, Germany) for the generation of recombinant histagged proteins in bacteria, pEGFP-C2 (Clontech, Palo Alto,CA, USA) for expression of EGFP fusion proteins in eukaryotic cells, a derivative of pcDNA3 (Clontech, Palo Alto,CA, USA) bearing a sequence tag derived from birch profilin (BiPro-tag (16) to yield sequencetagged proteins for immunoprecipitation experiments from HeLa cells. To mimic phosphorylation, VASP constructs were generated, in which S153, S235 and T274 were replaced by acidic residues. Site directed mutagenesis was performed according to manufacturer's instructions using the Quick-change kit (Stratagene, Heidelberg, Germany).
First, single phospho-mutants (S153D, S235D, T274E) were generated using the following primer pairs (5'-3'):
After sequencing, these constructs were further altered via additional site-directed mutagenesis to yield double mutants and the triple mutant. 
Protein expression, purification and analysis
Murine VASP and its derivatives were expressed in the Escherichia coli strain M15(pREP4).
Bacteria were transformed with VASP expression vectors (pQE30) and were grown in 2xYT medium at 30 °C. Protein expression was induced in late log-phase with 1 mM IPTG.
Bacteria were harvested after 3 hours post induction. Recombinant proteins were purified essentially as described in the manufacturer's protocol (Qiagen, Hilden, Germany). Protein elution was achieved by a stepwise histidine gradient (20, 30, 40 , 50 and 150 mM) in VASP elution buffer (50 mM sodium phosphate, pH 7.0, 100 mM KCl, 0.5 mM EDTA, 0.1 % Triton-X 100, 20 mM beta-mercaptoethanol, 5 mM benzamidine, 20 µM leupeptin, 50 µM pefabloc SC, 1 µM pepstatin A, 20 U/ml aprotinin). All fractions were analyzed by SDS-PAGE. VASP containing fractions with 70 % purity as judged by densitometric analysis (E.A.S.Y. RH apparatus, E.A.S.Y. Image Plus Software, Herolab, Wiesloch, Germany) were transferred into 50 mM sodium phosphate buffer pH 7.0 containing 100 mM KCl, 2.5 mM EGTA, 0.75 mM DTE, 0.1 % Triton-X 100 and protease inhibitors (see above). 2-3 mg VASP were purified from 1 l bacterial culture by this method. VASP proteins were stored in sodium phosphate buffer with 20 % glycerol added at -80 °C for up to two months.
Recombinant mouse profilin I and II (17) were purified by poly-L-proline affinity chromatography as described previously (18) with slight modifications: Profilin I and profilin II were eluted in 6 M urea and 8 M urea, respectively. Proteins were dialyzed against 10 mM Tris-HCl (pH 7.2), 0.2 mM CaCl 2 and 1.25 mM DTT.
Rabbit skeletal muscle actin was prepared from acetone powder (19) with an additional gel filtration step as described (20) . 
Phosphoamino acid analysis
One-dimensional phosphoamino acid analysis on thin-layer cellulose plates (Macherey and Nagel, Düren, Germany) was performed in pH 1.9-buffer (2.2 % formic acid, 7.8 % glacial acetic acid) essentially as described in (21) . Phospho-serine and phospho-threonine (Sigma, Deisenhofen, Germany) were used as internal standards and stained with ninhydrin.
Radiolabeled phosphoamino acids were detected by autoradiography.
Actin polymerization assay
The influence of VASP, profilin I or II on actin polymerization was determined by fluorimetry with 10% pyrene-labeled actin (22) added to unlabeled actin. Actin polymerization assays were performed essentially as described (8 fluorimeter (Perkin-Elmer, Langen, Germany).
Co-sedimentation and in vitro filament assays
Co-sedimentation assays were performed essentially as described in (8) . 10 µM actin was prepolymerized in buffer C (25 mM HEPES, pH 7.0, 0.2 mM CaCl 2 , 0.5 mM DTE, 1mM ATP, 25 mM NaCl, 2 mM MgCl 2 , KCl (15 mM or 50 mM) for 1 h at 37 °C. 2 µM F-actin was incubated with 2 µM VASP in buffer B for 1 h at room temperature. After high speed centrifugation (100000 x g, 60 min in an airfuge, Beckmann, München, Germany) pellets and supernatants were analyzed by SDS-PAGE. Coomassie Blue stained gels were analyzed densitometrically as described above. The percentage of VASP remaining in the supernatant compared to the total amount of VASP used in the experiment was calculated. In sedimentation assays to test for ternary VASP-profilin-actin complexes, pre-polymerization was omitted and actin filaments were polymerized in the presence of VASP and profilin.
2 µM unlabeled actin was polymerized in buffer C in the presence of 0.5 µM wild type VASP, the triple mutant and VASP phosphorylated by PKA, respectively, at 37 °C for one hour. Filaments were stained with rhodamine-labeled phalloidin (Sigma, Deisenhofen, Germany) and directly analyzed by fluorescence microscopy (Axiophot, Zeiss, Germany) using a cooled CCD camera (Roper Scientific, Tucson, AZ, USA) and the MetaMorph Software package (Visitron Systems, Puchheim, Germany).
Yeast-two-hybrid analysis
Yeast-two-hybrid analysis was performed with a GAL4-based MATCHMAKER System 3 (Clontech, Palo Alto, CA, USA) with yeast strains HF7C and Y187 according to manufacturer's instructions. VASP constructs were cloned into the "bait" vector pGBKT7 as well as the "prey" vector pGADT7 by use of EcoRI and XhoI/SalI restriction sites in the multiple cloning sites of either vector. A mouse cDNA library (embryonic day 17.5, Clontech, Palo Alto, CA, USA) was screened using either VASP or the VASP triple mutant as "bait".
DNA from positive clones was prepared from yeast and transformed into competent Escherichia coli (XL1 blue, Stratagene, Heidelberg, Germany) according to standard protocols. DNA sequencing was performed on an ABI PRISM 310 genetic analyzer (Perkin-Elmer, Langen, Germany). 
Cell culture and immunofluorescence
Solid phase binding assay
The interaction beTween VASP and both profilin isoforms was monitored by an ELISA assay. Microcolon ELISA plates (Greiner, Frickenhausen, Germany) were coated with 50 pmol profilin I or II per well, washed three times with 0.1% Tween-20 in PBS and blocked with 1 % bovine serum albumin in PBS for 2 h at room temperature. After an additional wash with PBS, increasing amounts of recombinant Bipro-tagged VASP were added (0.1 to 100 pmol in 100 µl PBS with 0.05% Tween-20 and 0.5 mM DTT) and incubated with either profilin I or profilin II for 2 h at room temperature. Unbound VASP was removed by three washing-steps (PBS, 0.1% Tween-20). Bound VASP was detected with a monoclonal antibody (4A6) specific for the BiPro-tag derived from birch profilin (16, 24) . After incubation with a peroxidase-conjugated polyvalent anti-mouse secondary antibody, enzymatic activity was measured using 2,2'-azino-bis(3ethylbenzthiazoline-6-sulfonic acid) as a substrate at 410 nm using an ELISA reader (Dynatech Laboratories, Billingshurst, UK).
Surface plasmon resonance studies
To determine the stoichiometry and dissociation constants (K D ) of VASP-profilin complexes, surface plasmon resonance studies were performed on a BIACORE 2000 analyzer (Biacore, Uppsla, Sweden). VASP (the ligand) was immobilized in 10 mM sodium acetate (pH 6.0) on a CM5 sensor chip by NHS/EDC chemistry, following the manufacturer's instructions. An indicator for the differences beTween the calculated and the measured curves is the chi 2 - value, which should be <10 for a global and <1 for a local fitting procedure. Furthermore RU max, exp was compared with a therotical RU max, theor value, that was calculated from the amount of VASP coupled to the sensor chip. RU max, theor can be obtained by the formula: excised from the gel and phosphate incorporation was analyzed by Cerenkov-counting. After 60 min 1.8 mol phosphate/mol VASP had been incorporated (Fig. 2b ). Phosphoamino acid analysis ( Fig. 2c ) revealed that VASP was mainly phosphorylated at serine residues even though some phosphothreonine was detectable. These results are in good agreement with a previous study on human VASP (11) which showed that VASP becomes phosphorylated at three residues, both in human platelets and in vitro: S157, S239 and T278, corresponding to S153, S235 and T274 in murine VASP (8) . In analogy to the data obtained by Butt and coworkers (11) we conclude that PKA first phosphorylates murine VASP at S153 in the proline-rich domain and subsequently at S235 and, to a much lesser extent, at T274.
VASP phosphorylation by PKA diminishes the actin nucleating activity of VASP as well as its binding to actin filaments
To analyze the influence of phosphorylation by PKA on VASP interaction with actin, we used unlabeled samples that had been prepared in parallel with the samples for the phosphate incorporation analysis. In a previous study we demonstrated that actin nucleation by VASP as well as its binding to actin filaments is salt-sensitive (8), indicating that the complex formation is based on electrostatic interactions. Hence all experiments were performed under low salt conditions (15 or 50 mM KCl).
Actin nucleation was monitored in a standard actin polymerization assay where 10 % of the G-actin used is labeled with pyrene ( Fig. 3a) . Actin filament formation causes an increase in fluorescence intensity giving a direct measurement of actin polymerization. When 1 µM Gactin was transferred into a buffer promoting actin polymerization, only negligible filament formation was observed. In the presence of 0.25 µM VASP, PKA and PKI a significant increase in fluorescence intensity was observed. Similar analysis of 0.25 µM VASP that had been phosphorylated by PKA for 0.5, 1.5, 3, 10 and 60 min, respectively, showed that actin polymerization was negatively influenced as detected by the continuous decrease in signal intensity with increasing phosphorylation. After three minutes incubation time, hardly any actin polymerization was observable, samples taken after 10 and 60 min were indistinguishable from the actin control. The phosphorylation analysis (Fig. 2) had already shown that most of the phosphate is incorporated during the first 10 min of incubation to more than 1 mol phosphate per mol VASP, meaning that S153 as well as S235 are phosphorylated.
While S153 is located in the proline-rich domain, S235 lies within the EVH2 domain which has been shown to mediate actin binding (8, 9) . Even though it is tempting to speculate that the decrease in actin nucleating activity is mainly due to phosphorylation of S235 we cannot rule out that there is an additive effect of both phosphorylation sites. Cosedimentation assays revealed that binding of VASP to actin filaments is also affected by VASP phosphorylation. 2 µM G-actin was pre-polymerized in actin polymerization buffer.
Wild type VASP (VASPwt) and phospho-VASP, respectively, were added in equimolar amounts. After centrifugation, pellets and supernatants were analyzed by SDS-PAGE (Fig. 3b) . His-tagged VASP had a slightly higher apparent molecular weight of approximately 50 kDa and almost quantitatively cosedimented with actin filaments. Phosphorylation decreased the amount of VASP that bound to actin filaments (Fig. 3c) . After 10 min phosphorylation approximately 57 % were recovered in the pellet, after 60 min most of the protein (84 %) remained in the supernatant. Phosphorylation in the proline-rich domain only (S153) as demonstrated by the shift to 54 kDa, seems to have little effect on F-actin binding, whereas additional phosphorylation at S235 in the EVH2 domain significantly reduces binding of VASP to actin filaments. However, again we cannot exclude the possibility that the mere accumulation of negative charges is responsible for the decrease in actin binding.
VASP phosphorylation can only partially be mimicked by introducing acidic amino acids
Since one cannot obtain a homogeneously phosphorylated population of VASP by in vitro phosphorylation, we sought to circumvent this problem by generating mutants of VASP mimicking phosphorylation (phospho-mutants), in which serine residues S153 and S235 were replaced by aspartic acid residues (S153D and S235D) and threonine T274 by a glutamic acid residue (T274E). Phospho-mutants comprising any combination of mutated phosphorylation sites were cloned, giving rise to seven mutants in total (a schematic overview of all VASP constructs is given in Fig. 7a ). First only the single phospho-mutants (S153D, S235D, T274E)
in which only one of the three residues had been replaced, were tested for actin nucleation by fluorimetric analysis in comparison to VASPwt at a molar ratio VASP:actin of 1:4 ( Fig. 4a ).
All three phospho-mutants reduced actin polymerization, but to a far lesser extent than in vitro phosphorylated VASP (compare Fig. 2a) . However, the phospho-mutant S235D, in which the serine residue located within the actin binding domain (EVH2) had been replaced, always had the largest effect as was determined in four independent experiments using different protein preparations.
To test for a possible cumulative effect of the three phosphorylation sites, we repeated the experiment using the triple phospho-mutant, in which all three residues had been exchanged for acidic residues (S153D/S235D/T274E). There was a marked reduction in signal intensity, but actin polymerization was still observed (Fig. 4b ). Since even this mutant did not abolish actin nucleation, as had been observed with VASPwt phosphorylated by PKA, the double mutants bearing two acidic residues were not tested in this assay.
Similar results were obtained, when the same four phospho-mutants were investigated for their binding to actin filaments as compared to VASPwt (Fig. 5) . Co-sedimentation assays with 2 µM actin and 1.5 µM VASP protein revealed that under low salt conditions (15 mM KCl) the single phospho-mutants were indistinguishable from the wild type protein. In contrast, a significant fraction of the triple phospho-mutant remained in the supernatant (Fig. 5a ). Increasing the salt concentration to 50 mM KCl (Fig. 5b ) enhanced this effect.
Binding of the triple mutant was significantly reduced under these conditions, whereas the single phospho-mutants were comparable to VASPwt. A densitometric analysis of the Coomassie-stained gels is shown in Fig. 5c .
Taken together, the data obtained with the phospho-mutants support our earlier findings that the VASP-actin complex is mainly based on electrostatic interactions (8) . Introducing an acidic amino acid does probably not yield a negative charge comparable to that obtained after that the shift was far better resolved on glycine-gels than tricine-gels (compare Figs. 5a and   5d ). However, these experiments still demonstrate that increasing the net negative charge causes a reduction in the VASP-actin complex formation. Furthermore, there seems to be indeed a cumulative effect when increasing the number of phosphorylation sites, with S235
having a greater effect on actin nucleation than S153 or T274. These data are consistent with our results obtained from VASP phosphorylated in vitro.
VASP phosphorylation alters actin filament organization
VASP does not only bind to actin filaments, but it also organizes them into bundles. In a previous study with rhodamine-phalloidin-labeled actin filaments (8) we demonstrated that both VASP and the EVH2 domain alone display a potent actin bundling activity. However, the morphology of the bundles induced by either protein differed markedly: When actin was allowed to polymerize in the presence of VASP at a molar ratio of 1:4 (VASP/EVH2:actin), VASP induced numerous short bundles emanating from a distinct center, thus giving the aggregates a star-like appearance, whereas the EVH2 domain led to the formation of long, flexible bundles. We performed similar assays in this study to investigate whether VASP phosphorylation would alter filament organization (Fig. 6 ). First we noticed that when VASP was added to pre-polymerized actin filaments, only bundles, but no star-shaped aggregates were observed (data not shown). Thus these stellar structures present after co-polymerization reflect actin nucleation in addition to mere bundling. Next we assayed actin filament formation in the presence of either VASPwt, the single phospho-mutants (S153D, S235D, T274E), the triple phospho-mutant (S153D/S235D/T274E), or phospho-VASP that had been phosphorylated by PKA for 60 min, respectively, at a molar ratio VASP:actin of 1:4. Actin filaments were stained with rhodamine-phalloidin and analyzed by fluorescence microscopy.
In contrast to the actin control (Fig. 6a ) VASPwt (Fig. 6b) induced the star-like aggregates as described previously (8) . In agreement with our results obtained from the actin polymerization assay (compare Fig. 4b ), the single phospho-mutants were indistinguishable from VASPwt (data not shown) and even the triple mutant was still capable to nucleate actin.
However, there were fewer star-like aggregates with the centers being less distinct and the actin filaments radiating from the latter being longer (Fig. 6c) . No star-like aggregates were observed for VASP phosphorylated by PKA (Fig. 6d) . Some residual bundling activity was noted yielding long, flexible filaments reminiscent of those previously observed for the EVH2
domain, but the bulk of the actin filaments remained as a fine network (see insert Fig. 6d ).
Given the heterogeneity of the sample, this bundling may be due to VASP phosphorylated to a lower extent or it may reflect that phosphorylated VASP retains some actin bundling activity, but cannot act as an actin nucleator.
VASP oligomerization is not affected by phosphorylation
VASP has been shown to be capable to oligomerize via the EVH2 domain (9) 2 . Since VASP oligomerization is most likely to participate in actin nucleation and filament binding and organization, we investigated whether VASP oligomerization was influenced by phosphorylation in a yeast-two-hybrid assay. VASPwt and the triple phospho-mutant were tested against all VASP constructs as well as deletion constructs comprising the EVH1 domain, the EVH1 and proline-rich domains, the proline-rich and EVH2 domains and the EVH2 domain, respectively (Fig. 7a) . In addition, the VASP phospho-mutants S153D and S153D/S235D were tested for self-association. The results are summarized in the upper part of Oligomerization may thus not be influenced by phosphorylation.
To confirm the data obtained from the yeast-two-hybrid analysis, we overexpressed VASPwt as well as all phospho-mutants in HeLa cells. All constructs were equipped with an Nterminal sequence tag from birch profilin (BiPro-tag) and immunoprecipitated from cell lysates. All VASP constructs immunoprecipitated endogenous VASP in comparable amounts, as detected by Western blot analysis in three independent experiments, using an antibody specific for human VASP (Fig. 8a) .
Phosphorylated VASP still binds to its ligands profilin, zyxin and vinculin.
A similar strategy was followed to investigate the influence of phosphorylation on VASPligand interactions. We tested for three known ligands of VASP: zyxin and vinculin to which VASP binds via the EVH1 domain (25) (26) (27) and profilin, which has been shown to bind to the proline-rich region of VASP (7). In the yeast two hybrid screen described above, multiple copies of a zyxin clone were identified, all comprising amino acids 1-455, thus containing the (Fig. 8b), zyxin (Fig. 8c) and profilin (Fig. 8d) . It is important to mention that the differences in signal intensities for either endogenous protein in Fig. 8 were not significant, as determined by six independent transfection experiments (data not shown).
However, these experiments revealed that phosphorylation did neither affect VASP-ligand interactions via the EVH1 nor the proline-rich domain.
VASP phospho-mutants show an intracellular distribution reminiscent of wild type VASP
VASPwt and the phospho-mutants were overexpressed as EGFP-constructs in murine C 2 C 12 myoblasts and analyzed for their intracellular distribution by fluorescence analysis (Fig. 9 ).
All VASP constructs clearly targeted to focal contacts and decorated stress fibers in a punctate pattern ( (Fig. 9b,e) and coumarine-labeled phalloidin (Fig. 9c,f) . The data are consistent with the yeast two hybrid analysis as well as the co-immunoprecipitation studies, indicating that VASP may target to cell-matrix adhesions irrespective of its state of phosphorylation, probably by binding to either vinculin or zyxin, both known to be present at these sites (reviewed in (1,28) ). (Fig. 10a ). 1 µM G-actin in polymerization buffer showed no significant polymerization. Adding equimolar amounts of either profilin isoform further diminished the fluorescence intensity, probably due to the sequestering of Gactin. With VASPwt present in the sample at a molar ratio of 1:4 (VASP:profilin-actin), both profilin isoforms enhanced actin polymerization compared to VASPwt alone. Hence, the sequestering effect of profilin is overcome by VASP recruiting profilin-actin complexes.
When the same experiment was performed using phospho-VASP that had been phosphorylated by PKA for 60 min, no actin polymerization was observed (Fig. 10b) .
However, the sequestering effect of either profilin isoform was still detectable.
Even though there was no significant difference regarding the sequestering effect beTween profilin I and profilin II, the latter always showed a stronger promotion of actin polymerization in the presence of VASPwt. This may be due to differences in the binding properties of profilin with respect to VASP. The interaction of VASPwt with either profilin isoform was investigated in surface plasmon resonance studies. VASPwt (ligand) was coated onto the sensor chip. Interaction kinetics were monitored by passing increasing concentrations (1, 3, 10 and 30 µM) of the analytes profilin I (Fig. 10c ) or profilin II (Fig. 10d) Repeating this experiment with VASP phosphorylated by PKA (60 min) did not show any significant differences (data not shown).
In conclusion, VASP may recruit profilin-actin complexes irrespective of its state of phosphorylation. In contrast, actin nucleation and polymerization as well as actin filament organization is negatively affected by VASP phosphorylation. 
Discussion
The present study investigates how VASP and its phosphorylation may contribute to the regulation of actin dynamics. VASP phosphorylation by cyclic nucleotide-dependent kinases and dephosphorylation by protein phosphatases I and II in vitro and in intact human platelets are well established (11, 32, 33) . Both, PKA and PKG phosphorylate VASP at three residues: S153, S235 and T274 (numbering according to murine VASP) with overlapping selectivity as is depicted in Fig. 1 . Our results obtained for VASP phosphorylation by PKA match previous results (11): S153 is the site preferred by PKA and is readily phosphorylated. This leads to a shift in the apparent molecular weight in SDS-PAGE. In contrast, phosphorylation of S235 and T274 cannot be monitored accordingly, since it does not cause any changes in electrophoretic mobility.
VASP is a multi-ligand protein that targets to the cytoplasmic face of cell-cell and cell-matrix contact sites in a variety of cells (4, 29) . It is thought to associate at these sites with other focal adhesion proteins like zyxin and vinculin and to promote actin polymerization through its recruitment of profilin-actin complexes. In the present study, we therefore investigated the influence of phosphorylation on the binding of VASP to these ligands. Complex formation with vinculin and zyxin was observed irrespective of the state of phosphorylation in vitro.
VASP mutants mimicking phosphorylation showed unaltered targeting to focal contacts in C 2 C 12 cells, supporting the observation that no changes in the subcellular distribution of VASP take place after treatment with cyclic nucleotide-elevating agents (34) .
Regarding VASP-profilin interactions, again no significant differences were observed with respect to phosphorylation, indicating that even the close proximity of S153 to the (GP 5 ) 3 module (residues 165-182) in the central VASP domain that binds to profilin (15) has no effect in vitro and in vivo, which is in good agreement with previous data (7). We did, however, note a difference in binding of profilins with respect to the isoform. While the affinity of profilin II for VASPwt lies in the upper nanomolar range and is significantly higher than that of profilin I, complex turnover is much faster for the latter. Similar binding affinities and binding kinetics have been shown recently using a (GP 5 ) 3 -peptide (35) .
Binding of VASP to actin is mediated via the EVH2 domain primarily through electrostatic interactions (8) . The EVH2 domain harbors two of the three phosphorylation sites, S235 and T274. Since T274 is only phosphorylated to a minor extent by PKA and PKG in vitro and in intact human platelets (11) (and this report) its influence on VASP-actin interaction remains elusive. In contrast, actin nucleation is clearly affected by VASP phosphorylation at the two serine residues. While phosphorylation of S153 alone has little effect on actin polymerization, additional phosphorylation at S235 prevents filament formation. However, to answer the question whether this is merely due to phosphorylation at S235 or whether both serine residues need to be phosphorylated requires further investigation. Evidence drawn from the analysis of phospho-mutants of VASP indicates that phosphorylation of S235 alone has a greater effect on actin polymerization, but a cumulative effect is observed for the triple mutant. The larger effect of S235 may be due to its location within a highly conserved basic region neighboring a KLRK motif (residues 230-233), similar to the one critical for G-actin binding in β4-thymosin (36) . Unfortunately, we were unable to demonstrate VASP-G-actin complexes in vitro, but their direct interaction is suggested by the actin nucleating activity of VASP.
Binding to pre-polymerized F-actin is also negatively affected by phosphorylation. While
VASPwt almost quantitatively cosediments with actin filaments, VASP phosphorylated by PKA for 60 min. remains mainly in the supernatant after high speed centrifugation. At present we cannot separate the effect of single phosphorylation sites from simple accumulation of negative charges by multiple phosphorylation. It was previously suggested that basic stretches within the EVH2 domain mediate VASP binding to F-actin (9) and that this complex relies on In a recent report, it was shown that recombinant VASP from baculovirus-infected Sf9 cells, phosphorylated to approximately 30 %, cosedimented to a higher extent with actin filaments when compared to the unphosphorylated, faster migrating VASP protein present in the same sample (37). However, as phosphorylation was only judged by the electrophoretic shift and the putative heterogeneity due to differential phosphorylation at S235 and T274, respectively, was not assessed, these data cannot be compared with the ones presented here.
VASP does not only bind to actin filaments, but it also organizes them into distinct bundles (8, 9) . When actin is polymerized in the presence of VASPwt, nucleation, polymerization and filament bundling take place simultaneously and result in the formation of star-shaped aggregates (8) (and this report). While replacing S153, S235 and T274 with acidic residues only leads to a decrease in nucleation, but filament bundling is still observable, phosphorylation by PKA abolishes both effects. Our data show that this is not due to reduced oligomerization of VASP which has been found confined to amino acids 277-380 (9).
We finally investigated the effect of VASP phosphorylation on the recruitment of profilinactin complexes. While both profilin isoforms increased actin polymerization by VASPwt, no actin polymerization was observed in the presence of phospho-VASP. As binding of a VASPderived (GP 5 ) 3 peptide to the poly-proline binding site of profilin does not significantly change the affinity of profilin for actin (35) , the effects observed in the present study are probably due to direct VASP-actin interactions.
Given the prominent salt-sensitivity of the interaction of VASP with actin in vitro (8) the observed association of both proteins under physiological conditions in cells remains to be explained. Full length VASP is mainly found at focal contacts, but it also decorates stress fibers in a punctate pattern reminiscent of the zyxin distribution (38) , indicating that VASP may be targeted to microfilaments even outside the focal contact area through its binding to zyxin. However, the isolated EVH2 domain which cannot interact with zyxin, exclusively binds to stress fibers in fibroblasts after overexpression, arguing for a direct VASP-actin interaction (8) , even at the ionic strength of the cytoplasm. Similar observations have been reported for calponin (39) . While this protein only bundles F-actin under low ionic strength in vitro, it associates with the actin cytoskeleton in different cell types (40, 41) . It has been
proposed that the local concentrations of actin and calponin may be sufficiently high to allow complex formation even under physiological ionic strength. An analogous explanation may apply to VASP.
High local concentrations of VASP and a high ratio of VASP to actin may be assumed either during specific phases of cell differentiation or in special cell types. An example for the first may be the observed essential role of VASP in the microfilament organization and the formation of adhesion zippers during cell-cell-contact formation in keratinocytes (29) .
An example for the latter may be the situation found in blood platelets which are rich in cyclic nucleotides and cyclic nucleotide-dependent kinases, especially PKG (10), as well as in actin and VASP. However, they are virtually devoid of the VASP relatives Ena/Mena and Evl (14) which may interfere with a VASP-actin-based regulation of microfilament assembly in adhesion complexes in other cells (42) . The "all-or-nothing" response during platelet activation requires the immediate, synchronous rearrangement of the microfilament system.
Platelets of VASP-deficient mice show enhanced agonist-induced aggregation (13, 14) , indicating that in these cells, VASP is indeed important as a negative regulator of actin polymerization. Our data suggest that this may directly be mediated by VASP phosphorylation.
In conclusion we propose a model of how VASP phosphorylation might regulate actin dynamics at cell adhesion sites (Fig. 11) . VASP may form complexes with its known ligands is preferentially phosphorylated by PKA, whereas S235 is the preferred phosphorylation site for PKG. 
